2Parkin DM, Bray F, Ferlay J,et al. Global cancer statistics, 2002[J]. CA Cancer J Clin,2005,55(2):74-108.
3Wen C. China's plans to curb cervical cancer[J]. Lancet Oncol, 2005,6(3) : 139-141.
4Roden R, Wu TC. How will HPV vaccines affect cervical cancer? [J]. Nat Rev Cancer,2006 10(6); 6:753-763.
5Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer [J]. Clin Sci,2006, 110(5): 525-541.
6Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study[J]. Lancet,2001,357 (9271):1831-1836.
7Scott M, Stites DP, Moscicki AB. Thl cytokine patterns in cervical human papillomavirus infection[J]. Clin Diagn Lab Immunol, 1999,6( 5 ) : 751-755.
8Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity[J]. Nat Rev Immunol, 2003, 3(2) : 133-146.
9Hsieh CS, Macatonia SE, Tripp CS, et al. Development of TH1 CD4^+ T cells through IL-12 produced by Listeriainduced macrophages [J]. Science,1993,260 (5107): 547-549.
10Nakahira M, Ahn HJ, Park WR,et al. Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1 [J]. J Immunol,2002,168(3): 1146-1153.
